Spil patents expiration
1. Aspruzyo Sprinkle patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11510878 | SPIL | Extended release multiparticulates of ranolazine |
Jan, 2038
(13 years from now) | |
| US10898444 | SPIL | Extended release multiparticulates of ranolazine |
Jan, 2038
(13 years from now) | |
Drugs and Companies using RANOLAZINE ingredient
Market Authorisation Date: 28 February, 2022
Treatment: NA
Dosage: GRANULES, EXTENDED RELEASE;ORAL
More Information on Dosage
ASPRUZYO SPRINKLE family patents
2. Kapspargo Sprinkle patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9504655 | SPIL | Capsule dosage form of metoprolol succinate |
Jul, 2035
(11 years from now) | |
| US9700530 | SPIL | Capsule dosage form of metoprolol succinate |
Jul, 2035
(11 years from now) | |
Drugs and Companies using METOPROLOL SUCCINATE ingredient
Market Authorisation Date: 26 January, 2018
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
KAPSPARGO SPRINKLE family patents